vs

Side-by-side financial comparison of CABOT CORP (CBT) and Qfin Holdings, Inc. (QFIN). Click either name above to swap in a different company.

CABOT CORP is the larger business by last-quarter revenue ($849.0M vs $731.2M, roughly 1.2× Qfin Holdings, Inc.). Qfin Holdings, Inc. runs the higher net margin — 27.5% vs 8.6%, a 18.9% gap on every dollar of revenue. Over the past eight quarters, Qfin Holdings, Inc.'s revenue compounded faster (16.4% CAGR vs -8.7%).

Cabot Corporation is an American specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company operates in over 20 countries with 36 manufacturing plants, eight research and development facilities, and 28 sales offices.

Qfin Holdings Inc. is a leading China-based fintech enterprise that mainly provides intelligent credit solutions, risk management technology support, and digital financial service tools. It collaborates with licensed financial institutions to serve individual consumers and micro, small and medium-sized enterprises across China, using big data and artificial intelligence to boost financial inclusion and operational efficiency.

CBT vs QFIN — Head-to-Head

Bigger by revenue
CBT
CBT
1.2× larger
CBT
$849.0M
$731.2M
QFIN
Higher net margin
QFIN
QFIN
18.9% more per $
QFIN
27.5%
8.6%
CBT
Faster 2-yr revenue CAGR
QFIN
QFIN
Annualised
QFIN
16.4%
-8.7%
CBT

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
CBT
CBT
QFIN
QFIN
Revenue
$849.0M
$731.2M
Net Profit
$73.0M
$201.2M
Gross Margin
24.9%
Operating Margin
15.2%
32.7%
Net Margin
8.6%
27.5%
Revenue YoY
-11.1%
Net Profit YoY
-21.5%
EPS (diluted)
$1.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBT
CBT
QFIN
QFIN
Q4 25
$849.0M
Q3 25
$899.0M
$731.2M
Q2 25
$923.0M
$728.1M
Q1 25
$936.0M
$646.4M
Q4 24
$955.0M
Q3 24
$1.0B
$622.7M
Q2 24
$1.0B
$572.4M
Q1 24
$1.0B
$575.2M
Net Profit
CBT
CBT
QFIN
QFIN
Q4 25
$73.0M
Q3 25
$43.0M
$201.2M
Q2 25
$101.0M
$241.6M
Q1 25
$94.0M
$247.6M
Q4 24
$93.0M
Q3 24
$137.0M
$256.3M
Q2 24
$109.0M
$189.4M
Q1 24
$84.0M
$160.7M
Gross Margin
CBT
CBT
QFIN
QFIN
Q4 25
24.9%
Q3 25
24.5%
Q2 25
26.4%
Q1 25
25.7%
Q4 24
24.6%
Q3 24
24.0%
Q2 24
25.2%
Q1 24
24.1%
Operating Margin
CBT
CBT
QFIN
QFIN
Q4 25
15.2%
Q3 25
15.2%
32.7%
Q2 25
18.1%
41.0%
Q1 25
17.3%
42.1%
Q4 24
16.2%
Q3 24
15.0%
52.4%
Q2 24
16.9%
47.7%
Q1 24
15.3%
32.8%
Net Margin
CBT
CBT
QFIN
QFIN
Q4 25
8.6%
Q3 25
4.8%
27.5%
Q2 25
10.9%
33.2%
Q1 25
10.0%
38.3%
Q4 24
9.7%
Q3 24
13.7%
41.2%
Q2 24
10.7%
33.1%
Q1 24
8.2%
27.9%
EPS (diluted)
CBT
CBT
QFIN
QFIN
Q4 25
$1.37
Q3 25
$0.80
Q2 25
$1.86
Q1 25
$1.69
Q4 24
$1.67
Q3 24
$2.41
Q2 24
$1.94
Q1 24
$1.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBT
CBT
QFIN
QFIN
Cash + ST InvestmentsLiquidity on hand
$230.0M
$6.5B
Total DebtLower is stronger
Stockholders' EquityBook value
$1.6B
$24.3B
Total Assets
$3.8B
$61.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBT
CBT
QFIN
QFIN
Q4 25
$230.0M
Q3 25
$258.0M
$6.5B
Q2 25
$239.0M
$5.3B
Q1 25
$213.0M
$8.6B
Q4 24
$183.0M
Q3 24
$223.0M
$4.3B
Q2 24
$197.0M
$6.3B
Q1 24
$206.0M
$5.3B
Total Debt
CBT
CBT
QFIN
QFIN
Q4 25
Q3 25
$1.1B
Q2 25
Q1 25
Q4 24
Q3 24
$1.1B
Q2 24
Q1 24
Stockholders' Equity
CBT
CBT
QFIN
QFIN
Q4 25
$1.6B
Q3 25
$1.6B
$24.3B
Q2 25
$1.5B
$24.1B
Q1 25
$1.4B
$23.1B
Q4 24
$1.4B
Q3 24
$1.4B
$22.9B
Q2 24
$1.3B
$22.6B
Q1 24
$1.4B
$22.1B
Total Assets
CBT
CBT
QFIN
QFIN
Q4 25
$3.8B
Q3 25
$3.8B
$61.4B
Q2 25
$3.8B
$59.8B
Q1 25
$3.8B
$55.6B
Q4 24
$3.6B
Q3 24
$3.7B
$47.0B
Q2 24
$3.6B
$47.0B
Q1 24
$3.6B
$47.4B
Debt / Equity
CBT
CBT
QFIN
QFIN
Q4 25
Q3 25
0.70×
Q2 25
Q1 25
Q4 24
Q3 24
0.75×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBT
CBT
QFIN
QFIN
Operating Cash FlowLast quarter
$126.0M
$351.4M
Free Cash FlowOCF − Capex
$57.0M
FCF MarginFCF / Revenue
6.7%
Capex IntensityCapex / Revenue
8.1%
Cash ConversionOCF / Net Profit
1.73×
1.75×
TTM Free Cash FlowTrailing 4 quarters
$401.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBT
CBT
QFIN
QFIN
Q4 25
$126.0M
Q3 25
$219.0M
$351.4M
Q2 25
$249.0M
$366.0M
Q1 25
$73.0M
$386.6M
Q4 24
$124.0M
Q3 24
$204.0M
$338.0M
Q2 24
$207.0M
$269.9M
Q1 24
$176.0M
$271.2M
Free Cash Flow
CBT
CBT
QFIN
QFIN
Q4 25
$57.0M
Q3 25
$155.0M
Q2 25
$188.0M
Q1 25
$1.0M
Q4 24
$47.0M
Q3 24
$112.0M
Q2 24
$155.0M
Q1 24
$133.0M
FCF Margin
CBT
CBT
QFIN
QFIN
Q4 25
6.7%
Q3 25
17.2%
Q2 25
20.4%
Q1 25
0.1%
Q4 24
4.9%
Q3 24
11.2%
Q2 24
15.3%
Q1 24
13.1%
Capex Intensity
CBT
CBT
QFIN
QFIN
Q4 25
8.1%
Q3 25
7.1%
Q2 25
6.6%
Q1 25
7.7%
Q4 24
8.1%
Q3 24
9.2%
Q2 24
5.1%
Q1 24
4.2%
Cash Conversion
CBT
CBT
QFIN
QFIN
Q4 25
1.73×
Q3 25
5.09×
1.75×
Q2 25
2.47×
1.52×
Q1 25
0.78×
1.56×
Q4 24
1.33×
Q3 24
1.49×
1.32×
Q2 24
1.90×
1.43×
Q1 24
2.10×
1.69×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBT
CBT

Reinforcement Materials$520.0M61%
Performance Chemicals$300.0M35%
Shipping And Handling$25.0M3%
Other Products And Services$4.0M0%

QFIN
QFIN

Segment breakdown not available.

Related Comparisons